Back to Results
First PageMeta Content
Stem cells / Transplantation medicine / Graft-versus-host disease / Hematopoietic stem cell transplantation / Cord blood / Hematology / Infliximab / Acute myeloid leukemia / Immunosuppressive drug / Medicine / Biology / Immunosuppressants


Use of Mesenchymal Stem Cells (Prochymal™) to Treat Pediatric Patients with Severe (Grade III-IV) acute Graft Versus Host Disease Refractory to Steroid and Other Agents Vinod K. Prasad, MD, MRCP, Blood and Marrow Trans
Add to Reading List

Document Date: 2013-12-30 23:23:25

Open Document

File Size: 185,01 KB

Share Result on Facebook

City

Miami / Milwaukee / Chicago / Durham / /

Company

Osiris Therapeutics Inc. / Hershey / /

Country

Columbia / /

Event

FDA Phase / /

Facility

University of Miami / Medical College of Wisconsin / College of Wisconsin / Children’s Memorial Hospital / Penn State Children’s Hospital / Duke University Medical Center / /

IndustryTerm

final product / /

MedicalCondition

fungal infection Sepsis / acute lymphocytic leukemia / sterility / myeloproliferative disease/eosinophilia / Host Disease / CMV encephalitis Respiratory failure / acute non-lymphocytic leukemia / hemophagocytic lymphohistiocytosis / acute promyelocytic leukemia / adrenoleukodystrophy / severe hepatitis / EBV LPD Sepsis / ANLL / acute myeloid leukemia / malignant osteopetrosis / syndrome / /

MedicalTreatment

immunosuppressive therapies / /

Organization

Medical College of Wisconsin / Milwaukee / University of Miami / Miami / College of Wisconsin / IRB / American Society / FDA / Children’s Memorial Hospital / Penn State Children’s Hospital / Duke University Medical Center / /

Person

David Jacobsohn / Joanne Kurtzberg / Kenneth G. Lucas / Rod Monroy / Julie-An Talano / Paul Szabolcs / Vinod K. Prasad / Gary I. Kleiner / /

Product

Zenapax / rituxan / prograf / hydrocortisone / cellcept / Prochymal™ / /

ProvinceOrState

Wisconsin / Illinois / Florida / North Carolina / /

Technology

Transplantation / Stem Cells / /

SocialTag